Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05057247
Title Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Glenn J. Hanna
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field